Myriad Genetics (MYGN) Tops Q2 EPS by 7c, Beats on Revenues; 'Raises Financial Guidance for Fiscal Year 2018'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. IBM
9. HOOD
10. ABBV

Go back to Myriad Genetics (MYGN) Tops Q2 EPS by 7c, Beats on Revenues; 'Raises Financial Guidance for Fiscal Year 2018'

Myriad Genetics (MYGN) PT Raised to $31 at Piper Jaffray

February 7, 2018 6:43 AM EST

Piper Jaffray raised its price target on Myriad Genetics (NASDAQ: MYGN) to $31.00 (from $29.00) while maintaining a Neutral rating.

... More